Boston Scientific Corporation [NYSE: BSX] closed the trading session at $42.11 on 04/29/22. The day’s price range saw the stock hit a low of $41.95, while the highest price level was $42.98. The company report on April 29, 2022 that Best Way to Navigate the Climate Disclosures Movement? Listen to the Institutional Investors Driving the Conversation..
Statements and Voting Guidance from Major Investors May Offer Companies a Roadmap For What Lies Ahead.
The stocks have a year to date performance of -0.87 percent and weekly performance of -4.08 percent. The stock has been moved at -2.61 percent over the last six months. The stock has performed -5.79 percent around the most recent 30 days and changed -1.47 percent over the most recent 3-months.
If compared to the average trading volume of 8.94M shares, BSX reached to a volume of 15067901 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Boston Scientific Corporation [BSX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BSX shares is $51.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BSX stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Boston Scientific Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 13, 2022. While these analysts kept the previous recommendation, BofA Securities raised their target price to Buy. The new note on the price target was released on March 02, 2022, representing the official price target for Boston Scientific Corporation stock. Previously, the target price had yet another raise to $51, while RBC Capital Mkts analysts kept a Outperform rating on BSX stock.
The Average True Range (ATR) for Boston Scientific Corporation is set at 1.30, with the Price to Sales ratio for BSX stock in the period of the last 12 months amounting to 5.02. The Price to Book ratio for the last quarter was 3.61, with the Price to Cash per share for the same quarter was set at 1.33. Price to Free Cash Flow for BSX in the course of the last twelve months was 37.75 with Quick ratio for the last quarter at 1.10.
BSX stock trade performance evaluation
Boston Scientific Corporation [BSX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.08. With this latest performance, BSX shares dropped by -5.79% in over the last four-week period, additionally sinking by -2.61% over the last 6 months – not to mention a drop of -3.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BSX stock in for the last two-week period is set at 41.04, with the RSI for the last a single of trading hit 36.83, and the three-weeks RSI is set at 43.76 for Boston Scientific Corporation [BSX]. The present Moving Average for the last 50 days of trading for this stock 43.75, while it was recorded at 43.02 for the last single week of trading, and 43.30 for the last 200 days.
Boston Scientific Corporation [BSX]: An insightful look at the core fundamentals
Boston Scientific Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.50.
Earnings per share (EPS) analysis for Boston Scientific Corporation [BSX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BSX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Boston Scientific Corporation go to 10.83%.
Boston Scientific Corporation [BSX]: Insider Ownership positions
There are presently around $54,671 million, or 93.10% of BSX stock, in the hands of institutional investors. The top three institutional holders of BSX stocks are: BLACKROCK INC. with ownership of 125,391,513, which is approximately 2.444% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 111,621,630 shares of the stock with an approximate value of $4.7 billion in BSX stocks shares; and FMR LLC, currently with $4.16 billion in BSX stock with ownership of nearly -8.079% of the company’s market capitalization.
413 institutional holders increased their position in Boston Scientific Corporation [NYSE:BSX] by around 70,595,049 shares. Additionally, 405 investors decreased positions by around 73,672,186 shares, while 154 investors held positions by with 1,154,019,263 shares. The mentioned changes placed institutional holdings at 1,298,286,498 shares, according to the latest SEC report filing. BSX stock had 112 new institutional investments in for a total of 5,151,928 shares, while 95 institutional investors sold positions of 6,088,420 shares during the same period.